Literature DB >> 32323353

Conventional Ultrasound and Contrast-Enhanced Ultrasound in the Diagnosis of Splenic Diseases: A Systematic Review and Meta-analysis.

Xing-Zhao Li1, Jun Song1, Zhi-Xia Sun1, Yan-Yan Yang1, Yuan-Qiang Lin1, Hui Wang1.   

Abstract

Accurate diagnosis of splenic diseases is important for timely and accurate treatment. The objective of this study was to compare the accuracy of contrast-enhanced ultrasound (CEUS) and conventional ultrasound (US) in detecting splenic lesions. A systematic literature search was undertaken, and 8 studies met the inclusion criteria. The sensitivity and specificity of the consolidated results of CEUS were 0.95 (95% confidence interval [CI], 0.92-0.97) and 0.97 (95% CI, 0.90-0.99), respectively (I2 = 27.4%; area under the curve [AUC] from a summary receiver operating characteristic curve = 0.97). The sensitivity and specificity of the consolidated results of conventional US were 0.70 (95% CI, 0.56-0.80) and 0.96 (95% CI, 0.76-0.99; I2 = 83.4%; AUC = 0.84). In this systematic review and meta-analysis, the sensitivity and specificity of CEUS were higher than those of conventional US in diagnosing splenic lesions. Contrast-enhanced US is a promising method for accurately diagnosing splenic lesions.
© 2020 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  contrast-enhanced ultrasound; meta-analysis; splenic diseases; systematic review; ultrasound

Mesh:

Substances:

Year:  2020        PMID: 32323353     DOI: 10.1002/jum.15291

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  2 in total

1.  The Role of Contrast-Enhanced Ultrasound in Differentiating Splenic Tuberculosis From Splenic Lymphoma.

Authors:  Wenzhi Zhang; Gaoyi Yang; Xu Zhang; Tu Ni
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

2.  Contrast-Enhanced Ultrasound Imaging Features of Focal Splenic Tuberculosis.

Authors:  Ying Zhang; Tianzhuo Yu; Wenzhi Zhang; Gaoyi Yang
Journal:  Med Sci Monit       Date:  2021-09-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.